Numbers beat street expectations. The market concern is that butterfat pricing will cut into their margins, but he feels the company has a lot of leeway to generate growth. The drop is a buying opportunity.
They more than replace the production and they don't payout 100% of their cash flow. A great energy trust. The one risk is gas pricing because the company continues to be largely unhedged.
Earnings are to be reported in early May and there are rumors that they'll miss their numbers and will take write-downs but he doesn't believe either is correct. A cheap stock and their financials will generate a lot of cash over the next few years.
Has had a great run over the last year. The valuation looks relatively inexpensive, but is not as cheap as it might appear. The big fear is that a Las Vegas outfit might deliver a big mousetrap.
Continues to like this stock. Expect them to get rid of the 13% coupon debt. Also expects further consolidation in the media industry in Canada and this could be a takeover.
Medical device companies are a bit of a minefield because big boys like Abbott, Baxter, Johnson & Johnson control the purchasing through a hospital. Interesting technology. Using a lot of cash. Wait to see their numbers. A high risk situation.